KFP
GILD icon

Kerr Financial Planning’s Gilead Sciences GILD Stock Holding History

Kerr Financial Planning’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6K Hold
100
– – 0.01% 336
2026
Q1 		$12.9K Hold
100
– – 0.01% 329
2025
Q4 		$15K Hold
100
– – 0.02% 314
2025
Q3 		$12.6K Buy
+100
New +$11.4K 0.02% 322

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kerr Financial Planning's GILD Position: Q2 2026 in Review

Kerr Financial Planning held its Gilead Sciences (GILD) position steady in Q2 2026 at 100 shares worth $12.6K. The position accounts for 0.01% of the portfolio, ranked #336.

Kerr Financial Planning first reported a position in GILD in Q3 2025 and has held it in 4 quarters since. The position peaked at $15K in Q4 2025. 2,265 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Kerr Financial Planning held 100 shares of Gilead Sciences worth $12.6K as of Q2 2026.
  • Kerr Financial Planning left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.01% of Kerr Financial Planning's portfolio in Q2 2026, its #336 holding.
  • Kerr Financial Planning first reported a position in Gilead Sciences in Q3 2025 and has held it in 4 quarters since.
  • Kerr Financial Planning's Gilead Sciences position peaked at $15K in Q4 2025.
  • 2,265 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Kerr Financial Planning's 13F filing for Q2 2026, filed 2 Jul 2026.